data_2kbl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kbl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.539 HD12 ' HA2' ' A' ' 18' ' ' GLY . 28.0 mm . . . . . 0 C--O 1.232 0.183 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.47 173.39 9.84 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.546 2.164 . . . . 0.0 112.672 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 134.04 56.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.73 20.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 9' ' ' ASP . 74.6 Cg_endo -79.27 61.44 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.603 2.202 . . . . 0.0 110.717 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 14.6 ptm180 -78.36 13.07 1.66 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.915 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 7' ' ' PRO . 12.7 p-10 -89.36 63.68 6.53 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.791 -1.549 . . . . 0.0 110.252 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 -4.39 8.97 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.638 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.757 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 89.3 mt-30 -137.95 103.52 5.0 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.15 94.96 0.54 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.911 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 10.2 m-30 -89.15 118.56 28.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.312 0.577 . . . . 0.0 112.424 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 15' ' ' ARG . 2.5 p -80.02 153.39 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.571 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.58 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 8.4 mtp-105 -82.94 121.71 27.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 15' ' ' ARG . 1.2 mptm? -131.09 174.11 10.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.54 100.49 0.38 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.595 1.188 . . . . 0.0 111.727 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 3' ' ' ILE . . . 58.13 18.22 33.72 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.677 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -121.75 142.37 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.911 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 12.3 m95 -112.81 126.5 55.51 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.85 135.29 45.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.918 -174.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.757 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.93 130.36 40.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -108.09 -29.68 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.544 ' OG ' HD22 ' A' ' 22' ' ' LEU . 45.5 p -43.83 -44.62 6.97 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.858 0.837 . . . . 0.0 111.59 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.508 HG23 ' N ' ' A' ' 26' ' ' PHE . 10.7 t -51.23 -34.38 31.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.224 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.508 ' N ' HG23 ' A' ' 25' ' ' THR . 24.1 m-85 -66.16 -49.56 66.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.511 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.209 -179.146 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.46 172.65 6.32 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.421 2.081 . . . . 0.0 112.938 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.551 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 76.0 ttt180 -72.01 131.03 42.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.44 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 20' ' ' TRP . . . -95.06 103.42 11.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 5' ' ' ARG . 96.2 Cg_endo -85.66 55.54 3.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.844 2.362 . . . . 0.0 111.193 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -84.13 69.01 10.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.773 1.273 . . . . 0.0 111.7 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.64 75.14 0.93 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.47 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 2.0 27.43 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.707 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 pt20 -146.66 103.91 3.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.4 105.45 1.16 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.327 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.821 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.0 m-30 -94.97 121.14 36.28 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.561 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.35 158.91 2.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.908 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -78.34 128.7 34.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.688 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -134.04 179.44 6.25 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.89 97.12 1.08 Allowed 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 123.014 1.388 . . . . 0.0 111.35 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.5 16.51 29.25 Favored Glycine 0 C--N 1.3 -1.46 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.966 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -123.56 148.74 46.05 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.821 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.5 m95 -109.34 125.97 52.9 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -133.62 140.57 46.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -74.84 134.69 41.67 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.21 8.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.449 -0.9 . . . . 0.0 113.115 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.415 ' OG ' HD21 ' A' ' 22' ' ' LEU . 26.2 p -42.99 -45.65 5.16 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 111.636 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -61.61 -20.95 63.92 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.156 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -76.68 -20.8 56.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 122.841 0.456 . . . . 0.0 111.184 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.625 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' ILE . 6.6 tt . . . . . 0 N--CA 1.439 -0.98 0 CA-C-O 121.045 0.45 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -60.72 171.28 3.69 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.124 1.882 . . . . 0.0 112.771 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' ARG . 23.2 tpt180 -72.57 126.31 29.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.297 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.57 111.33 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.8 57.71 5.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.779 2.319 . . . . 0.0 110.815 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 33.4 ptt180 -88.17 62.63 6.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.389 1.09 . . . . 0.0 113.815 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.67 -61.77 1.53 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.193 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.27 23.0 5.85 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 21.6 mt-30 -142.26 102.22 4.06 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 113.827 -1.186 . . . . 0.0 109.093 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.578 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -69.75 121.59 17.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.951 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.8 m-85 -109.07 124.94 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.411 0.624 . . . . 0.0 112.195 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.737 ' HB ' HD23 ' A' ' 23' ' ' LEU . 13.2 p -95.18 172.45 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.372 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.481 ' H ' HG21 ' A' ' 14' ' ' VAL . 31.9 tpt180 -90.62 118.85 30.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 9.0 tptp -118.7 -175.92 2.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.43 96.19 0.24 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.915 1.34 . . . . 0.0 111.556 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.54 9.66 9.78 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 111.716 -2.493 . . . . 0.0 113.611 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 44.9 mm-40 -124.14 153.51 41.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.951 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.3 m95 -97.89 141.22 31.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -143.28 141.77 26.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.69 -176.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.94 132.27 43.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD23 ' HB ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -119.39 -27.57 5.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 p -40.1 -51.58 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.792 0.806 . . . . 0.0 112.257 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -54.92 -35.69 64.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.721 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -60.55 -27.93 68.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.136 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.611 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.817 ' HB ' ' NE1' ' A' ' 20' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.694 ' HD2' HG21 ' A' ' 3' ' ' ILE . 73.0 Cg_endo -85.36 -40.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.845 2.363 . . . . 0.0 117.842 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 12.1 tpp180 -81.85 43.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . . . -104.63 91.41 4.11 Favored Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HB2' ' OD1' ' A' ' 9' ' ' ASP . 85.4 Cg_endo -86.34 140.89 6.63 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.936 1.758 . . . . 0.0 111.101 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -115.49 25.83 10.51 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.289 1.042 . . . . 0.0 111.716 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 7' ' ' PRO . 13.8 p-10 -92.52 59.55 3.38 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.664 -1.607 . . . . 0.0 113.311 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.75 16.32 80.86 Favored Glycine 0 CA--C 1.51 -0.221 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.336 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.597 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.477 ' N ' HD21 ' A' ' 22' ' ' LEU . . . -74.63 104.02 5.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.249 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.901 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 4.9 m-85 -95.97 118.74 33.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.343 0.592 . . . . 0.0 112.113 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 15' ' ' ARG . 7.4 p -84.02 162.7 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.745 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.429 ' N ' HG21 ' A' ' 14' ' ' VAL . 73.6 mtp85 -85.97 131.83 34.2 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -128.54 173.69 10.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -70.67 99.54 1.7 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.512 1.148 . . . . 0.0 109.773 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.25 10.79 53.91 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-N 112.476 -2.147 . . . . 0.0 113.734 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -124.95 147.53 48.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.901 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 43.0 m95 -108.16 137.44 46.13 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -142.39 138.84 29.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.138 -175.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.659 HD22 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.4 134.0 43.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.659 ' N ' HD22 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -114.46 -31.83 6.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.496 -177.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.628 ' OG ' HD23 ' A' ' 22' ' ' LEU . 13.5 p -46.69 -43.33 17.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.753 0.787 . . . . 0.0 111.224 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 t -52.25 -35.71 50.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.609 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE2' ' HA ' ' A' ' 23' ' ' LEU . 20.4 m-85 -62.63 -14.58 44.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.324 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.302 -179.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.89 175.43 4.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.0 112.986 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.15 120.6 16.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.67 115.99 41.14 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.946 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.03 53.9 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.734 2.29 . . . . 0.0 110.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -89.59 67.46 7.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.653 1.216 . . . . 0.0 112.516 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.23 69.37 3.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.583 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 21.96 57.3 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.844 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.716 ' HB3' ' CD2' ' A' ' 22' ' ' LEU . 65.7 mt-30 -143.55 114.54 7.78 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.38 132.77 43.4 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.238 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.77 ' HD1' ' N ' ' A' ' 21' ' ' VAL . 26.2 m-85 -117.48 123.7 46.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.883 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.531 ' HB ' HD21 ' A' ' 23' ' ' LEU . 2.5 p -84.48 156.56 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.497 ' N ' HG22 ' A' ' 14' ' ' VAL . 68.8 mtm180 -90.15 121.6 32.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.83 -174.17 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.57 99.27 0.96 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.414 1.102 . . . . 0.0 110.794 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.19 16.74 21.03 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.299 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -122.7 144.44 49.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.49 ' HB3' ' CD1' ' A' ' 13' ' ' TYR . 34.2 m95 -106.91 136.58 46.51 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.77 ' N ' ' HD1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -140.29 135.7 36.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.637 -176.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.716 ' CD2' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -66.03 127.89 33.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -120.84 -31.47 4.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.117 -1.033 . . . . 0.0 112.375 -176.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.443 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 5.2 p -47.34 -42.85 22.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.095 0.95 . . . . 0.0 110.318 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 26' ' ' PHE . 5.5 t -54.79 -43.6 73.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.072 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.497 ' H ' HG23 ' A' ' 25' ' ' THR . 14.9 m-30 -59.68 -42.67 93.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.998 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.597 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.567 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 28.6 mm . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.06 -175.68 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.452 2.102 . . . . 0.0 112.642 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -83.86 132.8 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.2 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' HB1' ' CE2' ' A' ' 20' ' ' TRP . . . -98.58 121.98 54.79 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.889 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.9 Cg_endo -87.34 49.03 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.096 2.53 . . . . 0.0 109.281 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 34.9 ptt180 -86.47 68.95 10.35 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.481 1.134 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.46 -78.53 0.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.277 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.58 19.72 44.07 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.637 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 90.2 mt-30 -135.22 106.72 6.86 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.682 ' HB2' HD23 ' A' ' 23' ' ' LEU . . . -69.52 102.56 1.84 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.3 m-85 -104.25 133.09 49.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.44 0.638 . . . . 0.0 111.968 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.589 HG23 ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -116.3 152.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.574 178.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.589 ' N ' HG23 ' A' ' 14' ' ' VAL . 23.8 ptt-85 -85.86 115.95 23.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.684 0.754 . . . . 0.0 111.236 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 18' ' ' GLY . 24.5 ttmm -103.38 86.2 2.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.975 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.26 -3.03 2.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.771 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 138.68 -9.32 3.41 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.234 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -98.3 139.57 33.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 117.376 0.588 . . . . 0.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.54 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 81.4 m95 -88.34 122.21 31.61 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.226 1.013 . . . . 0.0 108.582 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 m -133.08 148.72 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.457 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 22' ' ' LEU . 9.7 tp -78.77 147.92 33.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -84.49 -31.81 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.215 -177.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.49 ' OG ' ' HG ' ' A' ' 22' ' ' LEU . 23.9 p -48.49 -41.93 31.33 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.721 0.772 . . . . 0.0 111.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -52.97 -35.99 59.68 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.709 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -58.39 -59.82 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.311 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.725 -179.018 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 3' ' ' ILE . 21.5 mm . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.252 0.072 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.62 -176.33 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.33 2.02 . . . . 0.0 111.825 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -79.83 137.8 37.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.11 108.15 50.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 9' ' ' ASP . 76.2 Cg_endo -80.33 62.84 8.66 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.948 2.432 . . . . 0.0 109.958 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 15.1 ptm180 -78.68 14.42 1.32 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.125 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 7' ' ' PRO . 39.2 p-10 -88.73 64.97 7.54 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.848 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.69 7.47 10.66 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.642 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 53.3 mt-30 -150.24 111.98 4.52 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.21 101.66 2.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.86 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.6 m-30 -98.82 128.05 44.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.664 0.745 . . . . 0.0 112.665 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.488 HG23 ' N ' ' A' ' 15' ' ' ARG . 2.5 p -96.6 155.33 3.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.926 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.579 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 64.5 mtm180 -77.16 123.22 26.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.148 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.0 tppt? -117.86 32.89 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.418 1.104 . . . . 0.0 109.004 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.48 -26.77 0.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.277 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . -152.11 -7.95 0.11 Allowed Glycine 0 C--N 1.291 -1.949 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.008 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 35.8 mt-10 -123.11 144.03 49.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.353 0.577 . . . . 0.0 111.43 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.86 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 28.3 m95 -105.2 121.29 43.54 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -130.21 143.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.469 -174.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.642 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -76.98 138.85 39.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 -27.44 15.34 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.147 -177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 p -42.04 -48.14 4.59 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.98 0.895 . . . . 0.0 111.797 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.2 p -51.64 -33.75 34.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.511 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -58.75 -60.33 4.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.895 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 30.3 mm . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.641 0.257 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.55 175.13 7.43 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.69 2.26 . . . . 0.0 112.426 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -73.39 132.33 42.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.614 ' HB1' ' CE2' ' A' ' 20' ' ' TRP . . . -92.11 109.06 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.93 60.73 7.63 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.784 2.322 . . . . 0.0 110.492 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -82.85 65.6 8.05 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 123.024 1.392 . . . . 0.0 111.097 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.86 77.82 1.64 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.664 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.7 1.45 61.9 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.677 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 15.8 mt-30 -136.59 99.79 4.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.49 104.57 2.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.134 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.875 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.8 m-30 -95.66 130.23 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.233 0.539 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG11 HG23 ' A' ' 21' ' ' VAL . 7.3 p -97.81 160.77 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.095 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.3 ptp180 -80.2 128.43 33.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.893 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.816 ' HE2' HG22 ' A' ' 21' ' ' VAL . 19.4 ttmm -123.4 43.39 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.21 3.91 2.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.473 -1.239 . . . . 0.0 113.683 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 162.17 -21.2 0.19 Allowed Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 38.4 mt-10 -102.03 144.56 30.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.36 . . . . 0.0 111.937 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.875 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.2 m95 -98.81 128.81 45.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.261 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG22 ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.23 137.94 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.677 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -73.1 130.38 40.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.71 -26.35 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 p -40.22 -48.91 2.65 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.882 0.849 . . . . 0.0 112.289 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -58.64 -37.61 76.31 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.337 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -59.39 -57.25 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.321 -0.847 . . . . 0.0 109.973 -178.52 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.527 HD11 ' HA2' ' A' ' 18' ' ' GLY . 20.2 mt . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.483 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -166.56 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.948 2.432 . . . . 0.0 112.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -76.56 132.6 39.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 127.68 89.57 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.629 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.88 67.13 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.149 2.566 . . . . 0.0 111.63 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -87.54 57.16 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.947 1.355 . . . . 0.0 112.039 -178.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -100.42 47.92 0.92 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.685 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.34 2.53 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.18 112.5 10.52 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.422 ' O ' HD11 ' A' ' 22' ' ' LEU . . . -83.08 108.33 16.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.198 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.832 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.5 m-30 -95.11 136.26 35.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.958 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.67 157.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.587 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.467 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 69.3 mtm180 -84.39 123.96 30.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -118.68 177.97 4.64 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 100.99 0.72 Allowed 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.074 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . 61.9 12.36 35.33 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.177 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -123.91 148.06 47.17 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.832 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 27.7 m95 -109.88 130.88 55.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -141.22 152.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.628 -176.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.53 HD13 ' CE1' ' A' ' 13' ' ' TYR . 13.7 tp -76.27 140.94 41.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -27.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.663 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p -47.56 -45.46 27.0 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-O 121.941 0.877 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -55.34 -32.73 62.77 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.962 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -58.57 -34.6 71.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.753 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.69 155.0 71.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.082 1.855 . . . . 0.0 112.125 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 20.6 ttp-105 -70.68 119.08 14.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 20' ' ' TRP . . . -63.16 136.46 96.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.227 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 55.78 5.81 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.899 2.4 . . . . 0.0 110.22 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 31.9 ptt180 -87.83 65.09 8.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.405 1.097 . . . . 0.0 112.801 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -99.73 -50.5 4.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.908 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 10.82 15.85 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 7.6 pt20 -152.12 105.97 3.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.04 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.644 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -64.13 125.3 24.05 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.179 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 1.079 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 3.3 m-85 -112.93 127.84 56.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.42 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.07 162.19 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.691 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.584 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 46.6 mtm180 -92.65 122.64 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 25.9 mmtp -106.36 167.94 9.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -44.81 -29.58 0.81 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 21.29 0.13 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.115 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 58.2 mm-40 -126.39 146.69 49.96 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 1.079 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.1 m95 -104.6 128.14 52.54 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -134.58 147.42 29.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.044 -174.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.84 138.78 44.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 HD22 ' HB2' ' A' ' 12' ' ' ALA . 1.1 pp -124.54 -28.94 3.53 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 p -45.55 -44.11 12.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.141 0.972 . . . . 0.0 111.397 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.9 p -59.56 -29.5 67.97 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.769 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -67.33 -14.51 62.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.702 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.683 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -86.46 140.95 29.48 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.58 0.228 . . . . 0.0 110.768 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.539 HD12 ' HA2' ' A' ' 18' ' ' GLY . 28.0 mm -86.9 113.49 53.61 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.47 173.39 9.84 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.546 2.164 . . . . 0.0 112.672 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 134.04 56.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.73 20.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 9' ' ' ASP . 74.6 Cg_endo -79.27 61.44 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.603 2.202 . . . . 0.0 110.717 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 14.6 ptm180 -78.36 13.07 1.66 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.915 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 7' ' ' PRO . 12.7 p-10 -89.36 63.68 6.53 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.791 -1.549 . . . . 0.0 110.252 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 -4.39 8.97 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.638 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.757 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 89.3 mt-30 -137.95 103.52 5.0 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.15 94.96 0.54 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.911 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 10.2 m-30 -89.15 118.56 28.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.312 0.577 . . . . 0.0 112.424 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 15' ' ' ARG . 2.5 p -80.02 153.39 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.571 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.58 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 8.4 mtp-105 -82.94 121.71 27.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 15' ' ' ARG . 1.2 mptm? -131.09 174.11 10.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.54 100.49 0.38 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.595 1.188 . . . . 0.0 111.727 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 3' ' ' ILE . . . 58.13 18.22 33.72 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.677 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -121.75 142.37 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.911 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 12.3 m95 -112.81 126.5 55.51 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.85 135.29 45.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.918 -174.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.757 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.93 130.36 40.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -108.09 -29.68 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.544 ' OG ' HD22 ' A' ' 22' ' ' LEU . 45.5 p -43.83 -44.62 6.97 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.858 0.837 . . . . 0.0 111.59 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.508 HG23 ' N ' ' A' ' 26' ' ' PHE . 10.7 t -51.23 -34.38 31.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.224 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.508 ' N ' HG23 ' A' ' 25' ' ' THR . 24.1 m-85 -66.16 -49.56 66.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.511 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.209 -179.146 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.19 136.85 38.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.53 109.35 50.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.46 172.65 6.32 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.421 2.081 . . . . 0.0 112.938 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 76.0 ttt180 -72.01 131.03 42.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.44 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 20' ' ' TRP . . . -95.06 103.42 11.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 5' ' ' ARG . 96.2 Cg_endo -85.66 55.54 3.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.844 2.362 . . . . 0.0 111.193 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -84.13 69.01 10.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.773 1.273 . . . . 0.0 111.7 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.64 75.14 0.93 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.47 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 2.0 27.43 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.707 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 pt20 -146.66 103.91 3.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.4 105.45 1.16 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.327 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.821 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.0 m-30 -94.97 121.14 36.28 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.561 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.35 158.91 2.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.908 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -78.34 128.7 34.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.688 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -134.04 179.44 6.25 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.89 97.12 1.08 Allowed 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 123.014 1.388 . . . . 0.0 111.35 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.5 16.51 29.25 Favored Glycine 0 C--N 1.3 -1.46 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.966 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -123.56 148.74 46.05 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.821 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.5 m95 -109.34 125.97 52.9 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -133.62 140.57 46.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -74.84 134.69 41.67 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.21 8.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.449 -0.9 . . . . 0.0 113.115 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.415 ' OG ' HD21 ' A' ' 22' ' ' LEU . 26.2 p -42.99 -45.65 5.16 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 111.636 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -61.61 -20.95 63.92 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.156 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -76.68 -20.8 56.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 122.841 0.456 . . . . 0.0 111.184 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.625 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -91.15 169.19 11.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.927 0.394 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' ILE . 6.6 tt -80.15 125.02 82.43 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -60.72 171.28 3.69 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.124 1.882 . . . . 0.0 112.771 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' ARG . 23.2 tpt180 -72.57 126.31 29.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.297 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.57 111.33 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.8 57.71 5.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.779 2.319 . . . . 0.0 110.815 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 33.4 ptt180 -88.17 62.63 6.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.389 1.09 . . . . 0.0 113.815 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.67 -61.77 1.53 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.193 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.27 23.0 5.85 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.605 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 21.6 mt-30 -142.26 102.22 4.06 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 113.827 -1.186 . . . . 0.0 109.093 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -69.75 121.59 17.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.951 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.8 m-85 -109.07 124.94 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.411 0.624 . . . . 0.0 112.195 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.737 ' HB ' HD23 ' A' ' 23' ' ' LEU . 13.2 p -95.18 172.45 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.372 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' H ' HG21 ' A' ' 14' ' ' VAL . 31.9 tpt180 -90.62 118.85 30.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 9.0 tptp -118.7 -175.92 2.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.43 96.19 0.24 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.915 1.34 . . . . 0.0 111.556 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.54 9.66 9.78 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 111.716 -2.493 . . . . 0.0 113.611 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 44.9 mm-40 -124.14 153.51 41.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.951 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.3 m95 -97.89 141.22 31.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -143.28 141.77 26.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.69 -176.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.94 132.27 43.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD23 ' HB ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -119.39 -27.57 5.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 p -40.1 -51.58 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.792 0.806 . . . . 0.0 112.257 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -54.92 -35.69 64.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.721 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -60.55 -27.93 68.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.136 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.611 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -82.96 112.47 19.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.817 ' HB ' ' NE1' ' A' ' 20' ' ' TRP . 1.0 OUTLIER -101.19 140.12 21.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.694 ' HD2' HG21 ' A' ' 3' ' ' ILE . 73.0 Cg_endo -85.36 -40.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.845 2.363 . . . . 0.0 117.842 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 12.1 tpp180 -81.85 43.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . . . -104.63 91.41 4.11 Favored Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HB2' ' OD1' ' A' ' 9' ' ' ASP . 85.4 Cg_endo -86.34 140.89 6.63 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.936 1.758 . . . . 0.0 111.101 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -115.49 25.83 10.51 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.289 1.042 . . . . 0.0 111.716 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 7' ' ' PRO . 13.8 p-10 -92.52 59.55 3.38 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.664 -1.607 . . . . 0.0 113.311 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.75 16.32 80.86 Favored Glycine 0 CA--C 1.51 -0.221 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.336 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.597 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.477 ' N ' HD21 ' A' ' 22' ' ' LEU . . . -74.63 104.02 5.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.249 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.901 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 4.9 m-85 -95.97 118.74 33.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.343 0.592 . . . . 0.0 112.113 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 15' ' ' ARG . 7.4 p -84.02 162.7 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.745 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.429 ' N ' HG21 ' A' ' 14' ' ' VAL . 73.6 mtp85 -85.97 131.83 34.2 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -128.54 173.69 10.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -70.67 99.54 1.7 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.512 1.148 . . . . 0.0 109.773 178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.25 10.79 53.91 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-N 112.476 -2.147 . . . . 0.0 113.734 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -124.95 147.53 48.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.901 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 43.0 m95 -108.16 137.44 46.13 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -142.39 138.84 29.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.138 -175.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.659 HD22 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.4 134.0 43.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.659 ' N ' HD22 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -114.46 -31.83 6.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.496 -177.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.628 ' OG ' HD23 ' A' ' 22' ' ' LEU . 13.5 p -46.69 -43.33 17.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.753 0.787 . . . . 0.0 111.224 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 t -52.25 -35.71 50.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.609 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE2' ' HA ' ' A' ' 23' ' ' LEU . 20.4 m-85 -62.63 -14.58 44.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.324 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.302 -179.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -137.71 133.39 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.567 0.223 . . . . 0.0 110.462 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 mm -105.99 108.32 61.41 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.934 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.89 175.43 4.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.0 112.986 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.15 120.6 16.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.67 115.99 41.14 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.946 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.03 53.9 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.734 2.29 . . . . 0.0 110.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -89.59 67.46 7.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.653 1.216 . . . . 0.0 112.516 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.23 69.37 3.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.583 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 21.96 57.3 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.844 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.716 ' HB3' ' CD2' ' A' ' 22' ' ' LEU . 65.7 mt-30 -143.55 114.54 7.78 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.38 132.77 43.4 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.238 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.77 ' HD1' ' N ' ' A' ' 21' ' ' VAL . 26.2 m-85 -117.48 123.7 46.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.883 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.531 ' HB ' HD21 ' A' ' 23' ' ' LEU . 2.5 p -84.48 156.56 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.497 ' N ' HG22 ' A' ' 14' ' ' VAL . 68.8 mtm180 -90.15 121.6 32.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.83 -174.17 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.57 99.27 0.96 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.414 1.102 . . . . 0.0 110.794 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.19 16.74 21.03 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.299 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -122.7 144.44 49.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.49 ' HB3' ' CD1' ' A' ' 13' ' ' TYR . 34.2 m95 -106.91 136.58 46.51 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.77 ' N ' ' HD1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -140.29 135.7 36.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.637 -176.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.716 ' CD2' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -66.03 127.89 33.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -120.84 -31.47 4.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.117 -1.033 . . . . 0.0 112.375 -176.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.443 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 5.2 p -47.34 -42.85 22.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.095 0.95 . . . . 0.0 110.318 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 26' ' ' PHE . 5.5 t -54.79 -43.6 73.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.072 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.497 ' H ' HG23 ' A' ' 25' ' ' THR . 14.9 m-30 -59.68 -42.67 93.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.998 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.597 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -93.39 118.7 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.603 0.239 . . . . 0.0 110.681 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.567 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 28.6 mm -93.89 108.57 35.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.906 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.06 -175.68 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.452 2.102 . . . . 0.0 112.642 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -83.86 132.8 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.2 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' HB1' ' CE2' ' A' ' 20' ' ' TRP . . . -98.58 121.98 54.79 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.889 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.9 Cg_endo -87.34 49.03 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.096 2.53 . . . . 0.0 109.281 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 34.9 ptt180 -86.47 68.95 10.35 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.481 1.134 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.46 -78.53 0.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.277 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.58 19.72 44.07 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.637 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 90.2 mt-30 -135.22 106.72 6.86 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.682 ' HB2' HD23 ' A' ' 23' ' ' LEU . . . -69.52 102.56 1.84 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.3 m-85 -104.25 133.09 49.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.44 0.638 . . . . 0.0 111.968 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.589 HG23 ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -116.3 152.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.574 178.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.589 ' N ' HG23 ' A' ' 14' ' ' VAL . 23.8 ptt-85 -85.86 115.95 23.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.684 0.754 . . . . 0.0 111.236 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 18' ' ' GLY . 24.5 ttmm -103.38 86.2 2.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.975 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.26 -3.03 2.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.771 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 138.68 -9.32 3.41 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.234 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -98.3 139.57 33.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 117.376 0.588 . . . . 0.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.54 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 81.4 m95 -88.34 122.21 31.61 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.226 1.013 . . . . 0.0 108.582 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 m -133.08 148.72 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.457 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 22' ' ' LEU . 9.7 tp -78.77 147.92 33.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -84.49 -31.81 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.215 -177.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.49 ' OG ' ' HG ' ' A' ' 22' ' ' LEU . 23.9 p -48.49 -41.93 31.33 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.721 0.772 . . . . 0.0 111.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -52.97 -35.99 59.68 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.709 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -58.39 -59.82 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.311 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.725 -179.018 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -129.49 127.1 40.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 3' ' ' ILE . 21.5 mm -106.63 106.67 58.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.62 -176.33 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.33 2.02 . . . . 0.0 111.825 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -79.83 137.8 37.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.11 108.15 50.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 9' ' ' ASP . 76.2 Cg_endo -80.33 62.84 8.66 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.948 2.432 . . . . 0.0 109.958 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 15.1 ptm180 -78.68 14.42 1.32 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.125 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 7' ' ' PRO . 39.2 p-10 -88.73 64.97 7.54 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.848 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.69 7.47 10.66 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.642 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 53.3 mt-30 -150.24 111.98 4.52 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.21 101.66 2.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.86 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.6 m-30 -98.82 128.05 44.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.664 0.745 . . . . 0.0 112.665 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.488 HG23 ' N ' ' A' ' 15' ' ' ARG . 2.5 p -96.6 155.33 3.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.926 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.579 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 64.5 mtm180 -77.16 123.22 26.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.148 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 18' ' ' GLY . 3.0 tppt? -117.86 32.89 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.418 1.104 . . . . 0.0 109.004 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.48 -26.77 0.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.277 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . -152.11 -7.95 0.11 Allowed Glycine 0 C--N 1.291 -1.949 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.008 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 35.8 mt-10 -123.11 144.03 49.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.353 0.577 . . . . 0.0 111.43 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.86 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 28.3 m95 -105.2 121.29 43.54 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -130.21 143.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.469 -174.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.642 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -76.98 138.85 39.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 -27.44 15.34 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.147 -177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 p -42.04 -48.14 4.59 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.98 0.895 . . . . 0.0 111.797 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.2 p -51.64 -33.75 34.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.511 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -58.75 -60.33 4.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.895 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.322 -0.311 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -130.49 177.05 7.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 30.3 mm -91.51 108.97 33.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.433 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.55 175.13 7.43 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.69 2.26 . . . . 0.0 112.426 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -73.39 132.33 42.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.614 ' HB1' ' CE2' ' A' ' 20' ' ' TRP . . . -92.11 109.06 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.93 60.73 7.63 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.784 2.322 . . . . 0.0 110.492 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -82.85 65.6 8.05 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 123.024 1.392 . . . . 0.0 111.097 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.86 77.82 1.64 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.664 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.7 1.45 61.9 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.677 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 15.8 mt-30 -136.59 99.79 4.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.49 104.57 2.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.134 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.875 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.8 m-30 -95.66 130.23 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.233 0.539 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG11 HG23 ' A' ' 21' ' ' VAL . 7.3 p -97.81 160.77 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.095 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.3 ptp180 -80.2 128.43 33.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.893 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.816 ' HE2' HG22 ' A' ' 21' ' ' VAL . 19.4 ttmm -123.4 43.39 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.21 3.91 2.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.473 -1.239 . . . . 0.0 113.683 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 162.17 -21.2 0.19 Allowed Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 38.4 mt-10 -102.03 144.56 30.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.36 . . . . 0.0 111.937 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.875 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.2 m95 -98.81 128.81 45.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.261 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG22 ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.23 137.94 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.677 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -73.1 130.38 40.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.71 -26.35 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 p -40.22 -48.91 2.65 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.882 0.849 . . . . 0.0 112.289 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -58.64 -37.61 76.31 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.337 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -59.39 -57.25 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.321 -0.847 . . . . 0.0 109.973 -178.52 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.706 -0.557 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -73.96 117.98 16.38 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.527 HD11 ' HA2' ' A' ' 18' ' ' GLY . 20.2 mt -94.61 115.82 65.72 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.929 0.395 . . . . 0.0 111.483 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -166.56 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.948 2.432 . . . . 0.0 112.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -76.56 132.6 39.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 127.68 89.57 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.629 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.88 67.13 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.149 2.566 . . . . 0.0 111.63 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -87.54 57.16 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.947 1.355 . . . . 0.0 112.039 -178.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -100.42 47.92 0.92 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.685 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.34 2.53 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.18 112.5 10.52 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.422 ' O ' HD11 ' A' ' 22' ' ' LEU . . . -83.08 108.33 16.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.198 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.832 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.5 m-30 -95.11 136.26 35.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.958 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.67 157.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.587 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.467 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 69.3 mtm180 -84.39 123.96 30.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -118.68 177.97 4.64 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 100.99 0.72 Allowed 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.074 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . 61.9 12.36 35.33 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.177 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -123.91 148.06 47.17 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.832 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 27.7 m95 -109.88 130.88 55.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -141.22 152.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.628 -176.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.53 HD13 ' CE1' ' A' ' 13' ' ' TYR . 13.7 tp -76.27 140.94 41.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -27.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.663 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p -47.56 -45.46 27.0 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-O 121.941 0.877 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -55.34 -32.73 62.77 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.962 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -58.57 -34.6 71.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.753 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -85.22 120.51 26.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.0 110.192 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 mt -91.46 126.7 53.52 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.69 155.0 71.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.082 1.855 . . . . 0.0 112.125 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 20.6 ttp-105 -70.68 119.08 14.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 20' ' ' TRP . . . -63.16 136.46 96.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.227 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 55.78 5.81 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.899 2.4 . . . . 0.0 110.22 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 31.9 ptt180 -87.83 65.09 8.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.405 1.097 . . . . 0.0 112.801 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -99.73 -50.5 4.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.908 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 10.82 15.85 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 7.6 pt20 -152.12 105.97 3.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.04 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.644 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -64.13 125.3 24.05 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.179 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 1.079 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 3.3 m-85 -112.93 127.84 56.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.42 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.07 162.19 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.691 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.584 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 46.6 mtm180 -92.65 122.64 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 25.9 mmtp -106.36 167.94 9.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -44.81 -29.58 0.81 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 21.29 0.13 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.115 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 58.2 mm-40 -126.39 146.69 49.96 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 1.079 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.1 m95 -104.6 128.14 52.54 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -134.58 147.42 29.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.044 -174.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.84 138.78 44.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 HD22 ' HB2' ' A' ' 12' ' ' ALA . 1.1 pp -124.54 -28.94 3.53 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 p -45.55 -44.11 12.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.141 0.972 . . . . 0.0 111.397 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.9 p -59.56 -29.5 67.97 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.769 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -67.33 -14.51 62.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.702 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.683 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.626 HD13 ' HA2' ' A' ' 18' ' ' GLY . 28.0 mm . . . . . 0 C--O 1.232 0.183 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.47 173.39 9.84 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.546 2.164 . . . . 0.0 112.672 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 134.04 56.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.73 20.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 74.6 Cg_endo -79.27 61.44 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.603 2.202 . . . . 0.0 110.717 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 14.6 ptm180 -78.36 13.07 1.66 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.915 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -89.36 63.68 6.53 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.791 -1.549 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 -4.39 8.97 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.638 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.772 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 89.3 mt-30 -137.95 103.52 5.0 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.15 94.96 0.54 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.925 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 10.2 m-30 -89.15 118.56 28.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.312 0.577 . . . . 0.0 112.424 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.02 153.39 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.571 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.588 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 8.4 mtp-105 -82.94 121.71 27.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 15' ' ' ARG . 1.2 mptm? -131.09 174.11 10.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.54 100.49 0.38 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.595 1.188 . . . . 0.0 111.727 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.626 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 58.13 18.22 33.72 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.677 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -121.75 142.37 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.925 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 12.3 m95 -112.81 126.5 55.51 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.85 135.29 45.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.918 -174.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.93 130.36 40.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -108.09 -29.68 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 45.5 p -43.83 -44.62 6.97 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.858 0.837 . . . . 0.0 111.59 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 t -51.23 -34.38 31.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.224 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 24.1 m-85 -66.16 -49.56 66.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.511 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.209 -179.146 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.46 172.65 6.32 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.421 2.081 . . . . 0.0 112.938 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 76.0 ttt180 -72.01 131.03 42.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.44 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -95.06 103.42 11.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 5' ' ' ARG . 96.2 Cg_endo -85.66 55.54 3.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.844 2.362 . . . . 0.0 111.193 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -84.13 69.01 10.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.773 1.273 . . . . 0.0 111.7 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.64 75.14 0.93 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.47 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 2.0 27.43 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.722 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 pt20 -146.66 103.91 3.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.4 105.45 1.16 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.327 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.0 m-30 -94.97 121.14 36.28 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.561 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.35 158.91 2.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.908 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -78.34 128.7 34.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.688 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 7.7 tptp -134.04 179.44 6.25 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.89 97.12 1.08 Allowed 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 123.014 1.388 . . . . 0.0 111.35 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.5 16.51 29.25 Favored Glycine 0 C--N 1.3 -1.46 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.966 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 59.9 mm-40 -123.56 148.74 46.05 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.834 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.5 m95 -109.34 125.97 52.9 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -133.62 140.57 46.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -74.84 134.69 41.67 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.21 8.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.449 -0.9 . . . . 0.0 113.115 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.2 p -42.99 -45.65 5.16 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 111.636 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -61.61 -20.95 63.92 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.156 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -76.68 -20.8 56.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 122.841 0.456 . . . . 0.0 111.184 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.625 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 tt . . . . . 0 N--CA 1.439 -0.98 0 CA-C-O 121.045 0.45 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 21.5 Cg_exo -60.72 171.28 3.69 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.124 1.882 . . . . 0.0 112.771 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -72.57 126.31 29.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.297 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.57 111.33 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.8 57.71 5.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.779 2.319 . . . . 0.0 110.815 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 33.4 ptt180 -88.17 62.63 6.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.389 1.09 . . . . 0.0 113.815 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.67 -61.77 1.53 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.193 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.27 23.0 5.85 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.606 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 84.6 mt-30 -142.26 102.22 4.06 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 113.827 -1.186 . . . . 0.0 109.093 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -69.75 121.59 17.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.958 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.8 m-85 -109.07 124.94 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.411 0.624 . . . . 0.0 112.195 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 15' ' ' ARG . 13.2 p -95.18 172.45 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.372 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 14' ' ' VAL . 31.9 tpt180 -90.62 118.85 30.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 9.0 tptp -118.7 -175.92 2.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.43 96.19 0.24 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.915 1.34 . . . . 0.0 111.556 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.54 9.66 9.78 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 111.716 -2.493 . . . . 0.0 113.611 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 44.9 mm-40 -124.14 153.51 41.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.958 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.3 m95 -97.89 141.22 31.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -143.28 141.77 26.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.69 -176.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.94 132.27 43.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 ' HB ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -119.39 -27.57 5.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 p -40.1 -51.58 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.792 0.806 . . . . 0.0 112.257 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -54.92 -35.69 64.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.721 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.9 m-30 -60.55 -27.93 68.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.136 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.611 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.824 ' HB ' ' NE1' ' A' ' 20' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 3' ' ' ILE . 73.0 Cg_endo -85.36 -40.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.845 2.363 . . . . 0.0 117.842 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 12.1 tpp180 -81.85 43.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . . . -104.63 91.41 4.11 Favored Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HB2' ' OD1' ' A' ' 9' ' ' ASP . 85.4 Cg_endo -86.34 140.89 6.63 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.936 1.758 . . . . 0.0 111.101 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -115.49 25.83 10.51 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.289 1.042 . . . . 0.0 111.716 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 7' ' ' PRO . 13.8 p-10 -92.52 59.55 3.38 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.664 -1.607 . . . . 0.0 113.311 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.75 16.32 80.86 Favored Glycine 0 CA--C 1.51 -0.221 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.336 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.602 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -74.63 104.02 5.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.249 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.914 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 4.9 m-85 -95.97 118.74 33.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.343 0.592 . . . . 0.0 112.113 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.4 p -84.02 162.7 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.745 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 14' ' ' VAL . 73.6 mtp85 -85.97 131.83 34.2 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -128.54 173.69 10.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 99.54 1.7 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.512 1.148 . . . . 0.0 109.773 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.25 10.79 53.91 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-N 112.476 -2.147 . . . . 0.0 113.734 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -124.95 147.53 48.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 43.0 m95 -108.16 137.44 46.13 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -142.39 138.84 29.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.138 -175.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD11 ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -73.4 134.0 43.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.4 OUTLIER -114.46 -31.83 6.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.496 -177.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.5 p -46.69 -43.33 17.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.753 0.787 . . . . 0.0 111.224 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 t -52.25 -35.71 50.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.609 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 20.4 m-85 -62.63 -14.58 44.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.324 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.302 -179.345 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' HA2' ' A' ' 18' ' ' GLY . 37.6 mm . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.89 175.43 4.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.0 112.986 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.15 120.6 16.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -70.67 115.99 41.14 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.946 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.03 53.9 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.734 2.29 . . . . 0.0 110.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -89.59 67.46 7.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.653 1.216 . . . . 0.0 112.516 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.23 69.37 3.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.583 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 21.96 57.3 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.844 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 1.048 ' HB3' HD21 ' A' ' 22' ' ' LEU . 65.7 mt-30 -143.55 114.54 7.78 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -73.38 132.77 43.4 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.238 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.767 ' HD1' ' N ' ' A' ' 21' ' ' VAL . 26.2 m-85 -117.48 123.7 46.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.883 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.539 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -84.48 156.56 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 68.8 mtm180 -90.15 121.6 32.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.83 -174.17 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.57 99.27 0.96 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.414 1.102 . . . . 0.0 110.794 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 57.19 16.74 21.03 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.299 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -122.7 144.44 49.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.51 ' HB3' ' CD1' ' A' ' 13' ' ' TYR . 34.2 m95 -106.91 136.58 46.51 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.767 ' N ' ' HD1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -140.29 135.7 36.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.637 -176.458 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.048 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -66.03 127.89 33.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -120.84 -31.47 4.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.117 -1.033 . . . . 0.0 112.375 -176.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 5.2 p -47.34 -42.85 22.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.095 0.95 . . . . 0.0 110.318 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 26' ' ' PHE . 5.5 t -54.79 -43.6 73.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.072 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.469 ' CD1' HG23 ' A' ' 25' ' ' THR . 14.9 m-30 -59.68 -42.67 93.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.998 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.597 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.575 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 28.6 mm . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.06 -175.68 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.452 2.102 . . . . 0.0 112.642 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -83.86 132.8 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.2 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -98.58 121.98 54.79 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.889 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.9 Cg_endo -87.34 49.03 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.096 2.53 . . . . 0.0 109.281 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 34.9 ptt180 -86.47 68.95 10.35 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.481 1.134 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.46 -78.53 0.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.277 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.58 19.72 44.07 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.661 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 90.2 mt-30 -135.22 106.72 6.86 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.736 ' HB3' HD23 ' A' ' 23' ' ' LEU . . . -69.52 102.56 1.84 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 11' ' ' GLN . 5.3 m-85 -104.25 133.09 49.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.44 0.638 . . . . 0.0 111.968 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.3 152.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.574 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -85.86 115.95 23.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.684 0.754 . . . . 0.0 111.236 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE2' HG21 ' A' ' 21' ' ' VAL . 24.5 ttmm -103.38 86.2 2.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.975 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.26 -3.03 2.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.771 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 138.68 -9.32 3.41 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.234 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -98.3 139.57 33.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 117.376 0.588 . . . . 0.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 81.4 m95 -88.34 122.21 31.61 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.226 1.013 . . . . 0.0 108.582 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 m -133.08 148.72 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.457 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 23' ' ' LEU . 9.7 tp -78.77 147.92 33.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -84.49 -31.81 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.215 -177.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.493 ' OG ' ' HG ' ' A' ' 22' ' ' LEU . 23.9 p -48.49 -41.93 31.33 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.721 0.772 . . . . 0.0 111.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -52.97 -35.99 59.68 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.709 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -58.39 -59.82 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.311 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.725 -179.018 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.252 0.072 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.62 -176.33 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.33 2.02 . . . . 0.0 111.825 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -79.83 137.8 37.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -100.11 108.15 50.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -80.33 62.84 8.66 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.948 2.432 . . . . 0.0 109.958 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 15.1 ptm180 -78.68 14.42 1.32 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.125 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -88.73 64.97 7.54 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.848 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.69 7.47 10.66 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 53.3 mt-30 -150.24 111.98 4.52 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.21 101.66 2.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.6 m-30 -98.82 128.05 44.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.664 0.745 . . . . 0.0 112.665 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -96.6 155.33 3.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.926 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.596 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 64.5 mtm180 -77.16 123.22 26.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.148 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 21' ' ' VAL . 3.0 tppt? -117.86 32.89 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.418 1.104 . . . . 0.0 109.004 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.48 -26.77 0.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.277 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . -152.11 -7.95 0.11 Allowed Glycine 0 C--N 1.291 -1.949 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.008 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 35.8 mt-10 -123.11 144.03 49.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.353 0.577 . . . . 0.0 111.43 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.877 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 28.3 m95 -105.2 121.29 43.54 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -130.21 143.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.469 -174.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.647 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -76.98 138.85 39.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 -27.44 15.34 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.147 -177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' HD22 ' A' ' 22' ' ' LEU . 21.5 p -42.04 -48.14 4.59 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.98 0.895 . . . . 0.0 111.797 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.2 p -51.64 -33.75 34.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.511 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -58.75 -60.33 4.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.895 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.535 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 30.3 mm . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.641 0.257 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.55 175.13 7.43 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.69 2.26 . . . . 0.0 112.426 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -73.39 132.33 42.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -92.11 109.06 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.93 60.73 7.63 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.784 2.322 . . . . 0.0 110.492 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -82.85 65.6 8.05 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 123.024 1.392 . . . . 0.0 111.097 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.86 77.82 1.64 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.664 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.7 1.45 61.9 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.685 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 69.0 mt-30 -136.59 99.79 4.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.49 104.57 2.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.134 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.887 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.8 m-30 -95.66 130.23 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.233 0.539 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.3 p -97.81 160.77 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.095 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' N ' HG22 ' A' ' 14' ' ' VAL . 2.3 ptp180 -80.2 128.43 33.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.893 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.955 ' HE2' HG21 ' A' ' 21' ' ' VAL . 19.4 ttmm -123.4 43.39 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.21 3.91 2.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.473 -1.239 . . . . 0.0 113.683 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 162.17 -21.2 0.19 Allowed Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 38.4 mt-10 -102.03 144.56 30.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.36 . . . . 0.0 111.937 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.887 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.2 m95 -98.81 128.81 45.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.261 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.955 HG21 ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.23 137.94 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -73.1 130.38 40.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.71 -26.35 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 p -40.22 -48.91 2.65 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.882 0.849 . . . . 0.0 112.289 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -58.64 -37.61 76.31 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.337 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.0 m-30 -59.39 -57.25 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.49 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.321 -0.847 . . . . 0.0 109.973 -178.52 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.747 HD11 ' HA2' ' A' ' 18' ' ' GLY . 20.2 mt . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.483 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -166.56 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.948 2.432 . . . . 0.0 112.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -76.56 132.6 39.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 127.68 89.57 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.629 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.88 67.13 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.149 2.566 . . . . 0.0 111.63 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -87.54 57.16 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.947 1.355 . . . . 0.0 112.039 -178.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -100.42 47.92 0.92 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.685 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.34 2.53 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.625 ' HB3' HD13 ' A' ' 22' ' ' LEU . 15.1 mp0 -135.18 112.5 10.52 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 22' ' ' LEU . . . -83.08 108.33 16.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.198 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.852 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.5 m-30 -95.11 136.26 35.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.958 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.67 157.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.587 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 69.3 mtm180 -84.39 123.96 30.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -118.68 177.97 4.64 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 100.99 0.72 Allowed 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.074 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.747 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . 61.9 12.36 35.33 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.177 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -123.91 148.06 47.17 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.852 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 27.7 m95 -109.88 130.88 55.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -141.22 152.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.628 -176.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 11' ' ' GLN . 13.7 tp -76.27 140.94 41.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -27.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.663 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p -47.56 -45.46 27.0 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-O 121.941 0.877 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -55.34 -32.73 62.77 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.962 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -58.57 -34.6 71.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.753 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.69 155.0 71.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.082 1.855 . . . . 0.0 112.125 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 20.6 ttp-105 -70.68 119.08 14.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -63.16 136.46 96.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.227 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 55.78 5.81 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.899 2.4 . . . . 0.0 110.22 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 31.9 ptt180 -87.83 65.09 8.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.405 1.097 . . . . 0.0 112.801 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -99.73 -50.5 4.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.908 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 10.82 15.85 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 7.6 pt20 -152.12 105.97 3.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.04 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.631 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -64.13 125.3 24.05 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.179 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.108 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 3.3 m-85 -112.93 127.84 56.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.42 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 21' ' ' VAL . 3.9 p -91.07 162.19 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.691 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.593 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 46.6 mtm180 -92.65 122.64 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 25.9 mmtp -106.36 167.94 9.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -44.81 -29.58 0.81 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 21.29 0.13 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.115 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 58.2 mm-40 -126.39 146.69 49.96 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 1.108 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.1 m95 -104.6 128.14 52.54 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -134.58 147.42 29.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.044 -174.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.84 138.78 44.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.54 -28.94 3.53 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 p -45.55 -44.11 12.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.141 0.972 . . . . 0.0 111.397 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.9 p -59.56 -29.5 67.97 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.769 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -67.33 -14.51 62.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.702 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.683 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -86.46 140.95 29.48 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.58 0.228 . . . . 0.0 110.768 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.626 HD13 ' HA2' ' A' ' 18' ' ' GLY . 28.0 mm -86.9 113.49 53.61 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.47 173.39 9.84 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.546 2.164 . . . . 0.0 112.672 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 134.04 56.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.73 20.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 74.6 Cg_endo -79.27 61.44 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.603 2.202 . . . . 0.0 110.717 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 14.6 ptm180 -78.36 13.07 1.66 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.915 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -89.36 63.68 6.53 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.791 -1.549 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 -4.39 8.97 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.638 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.772 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 89.3 mt-30 -137.95 103.52 5.0 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.15 94.96 0.54 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.925 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 10.2 m-30 -89.15 118.56 28.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.312 0.577 . . . . 0.0 112.424 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.02 153.39 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.571 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.588 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 8.4 mtp-105 -82.94 121.71 27.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 15' ' ' ARG . 1.2 mptm? -131.09 174.11 10.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.54 100.49 0.38 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.595 1.188 . . . . 0.0 111.727 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.626 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 58.13 18.22 33.72 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.677 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -121.75 142.37 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.925 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 12.3 m95 -112.81 126.5 55.51 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.85 135.29 45.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.918 -174.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.93 130.36 40.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -108.09 -29.68 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 45.5 p -43.83 -44.62 6.97 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.858 0.837 . . . . 0.0 111.59 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 t -51.23 -34.38 31.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.224 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 24.1 m-85 -66.16 -49.56 66.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.511 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.209 -179.146 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.19 136.85 38.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.53 109.35 50.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.46 172.65 6.32 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.421 2.081 . . . . 0.0 112.938 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 76.0 ttt180 -72.01 131.03 42.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.44 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -95.06 103.42 11.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 5' ' ' ARG . 96.2 Cg_endo -85.66 55.54 3.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.844 2.362 . . . . 0.0 111.193 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -84.13 69.01 10.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.773 1.273 . . . . 0.0 111.7 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.64 75.14 0.93 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.47 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 2.0 27.43 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.722 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 pt20 -146.66 103.91 3.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.4 105.45 1.16 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.327 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.0 m-30 -94.97 121.14 36.28 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.561 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.35 158.91 2.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.908 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -78.34 128.7 34.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.688 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 7.7 tptp -134.04 179.44 6.25 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.89 97.12 1.08 Allowed 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 123.014 1.388 . . . . 0.0 111.35 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.5 16.51 29.25 Favored Glycine 0 C--N 1.3 -1.46 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.966 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 59.9 mm-40 -123.56 148.74 46.05 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.834 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.5 m95 -109.34 125.97 52.9 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -133.62 140.57 46.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -74.84 134.69 41.67 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.21 8.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.449 -0.9 . . . . 0.0 113.115 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.2 p -42.99 -45.65 5.16 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 111.636 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -61.61 -20.95 63.92 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.156 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -76.68 -20.8 56.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 122.841 0.456 . . . . 0.0 111.184 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.625 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -91.15 169.19 11.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.927 0.394 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 tt -80.15 125.02 82.43 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 21.5 Cg_exo -60.72 171.28 3.69 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.124 1.882 . . . . 0.0 112.771 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -72.57 126.31 29.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.297 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.57 111.33 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.8 57.71 5.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.779 2.319 . . . . 0.0 110.815 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 33.4 ptt180 -88.17 62.63 6.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.389 1.09 . . . . 0.0 113.815 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.67 -61.77 1.53 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.193 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.27 23.0 5.85 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.606 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 84.6 mt-30 -142.26 102.22 4.06 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 113.827 -1.186 . . . . 0.0 109.093 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -69.75 121.59 17.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.958 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.8 m-85 -109.07 124.94 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.411 0.624 . . . . 0.0 112.195 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 15' ' ' ARG . 13.2 p -95.18 172.45 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.372 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 14' ' ' VAL . 31.9 tpt180 -90.62 118.85 30.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 9.0 tptp -118.7 -175.92 2.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.43 96.19 0.24 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.915 1.34 . . . . 0.0 111.556 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.54 9.66 9.78 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 111.716 -2.493 . . . . 0.0 113.611 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 44.9 mm-40 -124.14 153.51 41.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.958 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.3 m95 -97.89 141.22 31.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -143.28 141.77 26.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.69 -176.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.94 132.27 43.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 ' HB ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -119.39 -27.57 5.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 p -40.1 -51.58 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.792 0.806 . . . . 0.0 112.257 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -54.92 -35.69 64.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.721 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.9 m-30 -60.55 -27.93 68.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.136 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.611 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -82.96 112.47 19.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.824 ' HB ' ' NE1' ' A' ' 20' ' ' TRP . 1.0 OUTLIER -101.19 140.12 21.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 3' ' ' ILE . 73.0 Cg_endo -85.36 -40.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.845 2.363 . . . . 0.0 117.842 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 12.1 tpp180 -81.85 43.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . . . -104.63 91.41 4.11 Favored Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HB2' ' OD1' ' A' ' 9' ' ' ASP . 85.4 Cg_endo -86.34 140.89 6.63 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.936 1.758 . . . . 0.0 111.101 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -115.49 25.83 10.51 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.289 1.042 . . . . 0.0 111.716 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 7' ' ' PRO . 13.8 p-10 -92.52 59.55 3.38 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.664 -1.607 . . . . 0.0 113.311 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.75 16.32 80.86 Favored Glycine 0 CA--C 1.51 -0.221 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.336 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.602 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -74.63 104.02 5.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.249 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.914 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 4.9 m-85 -95.97 118.74 33.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.343 0.592 . . . . 0.0 112.113 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.4 p -84.02 162.7 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.745 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 14' ' ' VAL . 73.6 mtp85 -85.97 131.83 34.2 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -128.54 173.69 10.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 99.54 1.7 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.512 1.148 . . . . 0.0 109.773 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.25 10.79 53.91 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-N 112.476 -2.147 . . . . 0.0 113.734 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -124.95 147.53 48.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 43.0 m95 -108.16 137.44 46.13 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -142.39 138.84 29.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.138 -175.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD11 ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -73.4 134.0 43.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.4 OUTLIER -114.46 -31.83 6.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.496 -177.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.5 p -46.69 -43.33 17.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.753 0.787 . . . . 0.0 111.224 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 t -52.25 -35.71 50.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.609 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 20.4 m-85 -62.63 -14.58 44.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.324 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.302 -179.345 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -137.71 133.39 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.567 0.223 . . . . 0.0 110.462 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' HA2' ' A' ' 18' ' ' GLY . 37.6 mm -105.99 108.32 61.41 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.934 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.89 175.43 4.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.0 112.986 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.15 120.6 16.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -70.67 115.99 41.14 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.946 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.03 53.9 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.734 2.29 . . . . 0.0 110.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -89.59 67.46 7.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.653 1.216 . . . . 0.0 112.516 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.23 69.37 3.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.583 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 21.96 57.3 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.844 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 1.048 ' HB3' HD21 ' A' ' 22' ' ' LEU . 65.7 mt-30 -143.55 114.54 7.78 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -73.38 132.77 43.4 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.238 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.767 ' HD1' ' N ' ' A' ' 21' ' ' VAL . 26.2 m-85 -117.48 123.7 46.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.883 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.539 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -84.48 156.56 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 68.8 mtm180 -90.15 121.6 32.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.83 -174.17 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.57 99.27 0.96 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.414 1.102 . . . . 0.0 110.794 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 57.19 16.74 21.03 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.299 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -122.7 144.44 49.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.51 ' HB3' ' CD1' ' A' ' 13' ' ' TYR . 34.2 m95 -106.91 136.58 46.51 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.767 ' N ' ' HD1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -140.29 135.7 36.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.637 -176.458 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.048 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -66.03 127.89 33.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -120.84 -31.47 4.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.117 -1.033 . . . . 0.0 112.375 -176.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 5.2 p -47.34 -42.85 22.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.095 0.95 . . . . 0.0 110.318 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 26' ' ' PHE . 5.5 t -54.79 -43.6 73.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.072 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.469 ' CD1' HG23 ' A' ' 25' ' ' THR . 14.9 m-30 -59.68 -42.67 93.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.998 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.597 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -93.39 118.7 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.603 0.239 . . . . 0.0 110.681 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.575 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 28.6 mm -93.89 108.57 35.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.906 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.06 -175.68 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.452 2.102 . . . . 0.0 112.642 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -83.86 132.8 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.2 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -98.58 121.98 54.79 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.889 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.9 Cg_endo -87.34 49.03 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.096 2.53 . . . . 0.0 109.281 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 34.9 ptt180 -86.47 68.95 10.35 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.481 1.134 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.46 -78.53 0.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.277 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.58 19.72 44.07 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.661 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 90.2 mt-30 -135.22 106.72 6.86 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.736 ' HB3' HD23 ' A' ' 23' ' ' LEU . . . -69.52 102.56 1.84 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 11' ' ' GLN . 5.3 m-85 -104.25 133.09 49.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.44 0.638 . . . . 0.0 111.968 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.3 152.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.574 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -85.86 115.95 23.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.684 0.754 . . . . 0.0 111.236 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE2' HG21 ' A' ' 21' ' ' VAL . 24.5 ttmm -103.38 86.2 2.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.975 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.26 -3.03 2.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.771 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 138.68 -9.32 3.41 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.234 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -98.3 139.57 33.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 117.376 0.588 . . . . 0.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 81.4 m95 -88.34 122.21 31.61 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.226 1.013 . . . . 0.0 108.582 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 m -133.08 148.72 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.457 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 23' ' ' LEU . 9.7 tp -78.77 147.92 33.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -84.49 -31.81 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.215 -177.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.493 ' OG ' ' HG ' ' A' ' 22' ' ' LEU . 23.9 p -48.49 -41.93 31.33 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.721 0.772 . . . . 0.0 111.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -52.97 -35.99 59.68 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.709 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -58.39 -59.82 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.311 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.725 -179.018 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -129.49 127.1 40.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -106.63 106.67 58.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.022 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.62 -176.33 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.33 2.02 . . . . 0.0 111.825 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -79.83 137.8 37.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -100.11 108.15 50.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -80.33 62.84 8.66 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.948 2.432 . . . . 0.0 109.958 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 15.1 ptm180 -78.68 14.42 1.32 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.125 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -88.73 64.97 7.54 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.848 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.69 7.47 10.66 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 53.3 mt-30 -150.24 111.98 4.52 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.21 101.66 2.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.6 m-30 -98.82 128.05 44.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.664 0.745 . . . . 0.0 112.665 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -96.6 155.33 3.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.926 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.596 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 64.5 mtm180 -77.16 123.22 26.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.148 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 21' ' ' VAL . 3.0 tppt? -117.86 32.89 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.418 1.104 . . . . 0.0 109.004 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.48 -26.77 0.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.277 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . -152.11 -7.95 0.11 Allowed Glycine 0 C--N 1.291 -1.949 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.008 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 35.8 mt-10 -123.11 144.03 49.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.353 0.577 . . . . 0.0 111.43 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.877 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 28.3 m95 -105.2 121.29 43.54 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -130.21 143.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.469 -174.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.647 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -76.98 138.85 39.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 -27.44 15.34 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.147 -177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' HD22 ' A' ' 22' ' ' LEU . 21.5 p -42.04 -48.14 4.59 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.98 0.895 . . . . 0.0 111.797 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.2 p -51.64 -33.75 34.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.511 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -58.75 -60.33 4.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.895 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.322 -0.311 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -130.49 177.05 7.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.535 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 30.3 mm -91.51 108.97 33.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.433 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.55 175.13 7.43 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.69 2.26 . . . . 0.0 112.426 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -73.39 132.33 42.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -92.11 109.06 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.93 60.73 7.63 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.784 2.322 . . . . 0.0 110.492 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -82.85 65.6 8.05 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 123.024 1.392 . . . . 0.0 111.097 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.86 77.82 1.64 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.664 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.7 1.45 61.9 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.685 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 69.0 mt-30 -136.59 99.79 4.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.49 104.57 2.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.134 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.887 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.8 m-30 -95.66 130.23 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.233 0.539 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.3 p -97.81 160.77 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.095 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' N ' HG22 ' A' ' 14' ' ' VAL . 2.3 ptp180 -80.2 128.43 33.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.893 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.955 ' HE2' HG21 ' A' ' 21' ' ' VAL . 19.4 ttmm -123.4 43.39 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.21 3.91 2.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.473 -1.239 . . . . 0.0 113.683 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 162.17 -21.2 0.19 Allowed Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 38.4 mt-10 -102.03 144.56 30.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.36 . . . . 0.0 111.937 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.887 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.2 m95 -98.81 128.81 45.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.261 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.955 HG21 ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.23 137.94 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -73.1 130.38 40.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.71 -26.35 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 p -40.22 -48.91 2.65 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.882 0.849 . . . . 0.0 112.289 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -58.64 -37.61 76.31 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.337 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.0 m-30 -59.39 -57.25 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.49 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.321 -0.847 . . . . 0.0 109.973 -178.52 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.706 -0.557 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -73.96 117.98 16.38 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.747 HD11 ' HA2' ' A' ' 18' ' ' GLY . 20.2 mt -94.61 115.82 65.72 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.929 0.395 . . . . 0.0 111.483 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -166.56 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.948 2.432 . . . . 0.0 112.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -76.56 132.6 39.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 127.68 89.57 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.629 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.88 67.13 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.149 2.566 . . . . 0.0 111.63 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -87.54 57.16 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.947 1.355 . . . . 0.0 112.039 -178.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -100.42 47.92 0.92 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.685 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.34 2.53 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.625 ' HB3' HD13 ' A' ' 22' ' ' LEU . 15.1 mp0 -135.18 112.5 10.52 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 22' ' ' LEU . . . -83.08 108.33 16.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.198 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.852 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.5 m-30 -95.11 136.26 35.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.958 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.67 157.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.587 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 69.3 mtm180 -84.39 123.96 30.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -118.68 177.97 4.64 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 100.99 0.72 Allowed 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.074 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.747 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . 61.9 12.36 35.33 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.177 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -123.91 148.06 47.17 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.852 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 27.7 m95 -109.88 130.88 55.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -141.22 152.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.628 -176.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 11' ' ' GLN . 13.7 tp -76.27 140.94 41.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -27.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.663 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p -47.56 -45.46 27.0 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-O 121.941 0.877 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -55.34 -32.73 62.77 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.962 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -58.57 -34.6 71.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.753 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -85.22 120.51 26.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.0 110.192 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 mt -91.46 126.7 53.52 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.69 155.0 71.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.082 1.855 . . . . 0.0 112.125 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 20.6 ttp-105 -70.68 119.08 14.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -63.16 136.46 96.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.227 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 55.78 5.81 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.899 2.4 . . . . 0.0 110.22 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 31.9 ptt180 -87.83 65.09 8.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.405 1.097 . . . . 0.0 112.801 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -99.73 -50.5 4.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.908 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 10.82 15.85 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 7.6 pt20 -152.12 105.97 3.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.04 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.631 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -64.13 125.3 24.05 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.179 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.108 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 3.3 m-85 -112.93 127.84 56.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.42 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 21' ' ' VAL . 3.9 p -91.07 162.19 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.691 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.593 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 46.6 mtm180 -92.65 122.64 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 25.9 mmtp -106.36 167.94 9.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -44.81 -29.58 0.81 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 21.29 0.13 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.115 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 58.2 mm-40 -126.39 146.69 49.96 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 1.108 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.1 m95 -104.6 128.14 52.54 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -134.58 147.42 29.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.044 -174.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.84 138.78 44.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.54 -28.94 3.53 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 p -45.55 -44.11 12.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.141 0.972 . . . . 0.0 111.397 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.9 p -59.56 -29.5 67.97 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.769 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -67.33 -14.51 62.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.702 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.683 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.626 HD13 ' HA2' ' A' ' 18' ' ' GLY . 28.0 mm . . . . . 0 C--O 1.232 0.183 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.47 173.39 9.84 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.546 2.164 . . . . 0.0 112.672 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 134.04 56.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.73 20.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 74.6 Cg_endo -79.27 61.44 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.603 2.202 . . . . 0.0 110.717 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 14.6 ptm180 -78.36 13.07 1.66 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.915 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -89.36 63.68 6.53 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.791 -1.549 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 -4.39 8.97 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.638 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.772 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 89.3 mt-30 -137.95 103.52 5.0 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.15 94.96 0.54 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.925 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 10.2 m-30 -89.15 118.56 28.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.312 0.577 . . . . 0.0 112.424 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.02 153.39 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.571 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.588 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 8.4 mtp-105 -82.94 121.71 27.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 15' ' ' ARG . 1.2 mptm? -131.09 174.11 10.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.54 100.49 0.38 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.595 1.188 . . . . 0.0 111.727 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.626 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 58.13 18.22 33.72 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.677 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -121.75 142.37 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.925 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 12.3 m95 -112.81 126.5 55.51 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.85 135.29 45.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.918 -174.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.93 130.36 40.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -108.09 -29.68 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 45.5 p -43.83 -44.62 6.97 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.858 0.837 . . . . 0.0 111.59 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 t -51.23 -34.38 31.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.224 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 24.1 m-85 -66.16 -49.56 66.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.511 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.209 -179.146 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.46 172.65 6.32 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.421 2.081 . . . . 0.0 112.938 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 76.0 ttt180 -72.01 131.03 42.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.44 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -95.06 103.42 11.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 5' ' ' ARG . 96.2 Cg_endo -85.66 55.54 3.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.844 2.362 . . . . 0.0 111.193 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -84.13 69.01 10.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.773 1.273 . . . . 0.0 111.7 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.64 75.14 0.93 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.47 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 2.0 27.43 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.722 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 pt20 -146.66 103.91 3.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.4 105.45 1.16 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.327 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.0 m-30 -94.97 121.14 36.28 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.561 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.35 158.91 2.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.908 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -78.34 128.7 34.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.688 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 7.7 tptp -134.04 179.44 6.25 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.89 97.12 1.08 Allowed 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 123.014 1.388 . . . . 0.0 111.35 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.5 16.51 29.25 Favored Glycine 0 C--N 1.3 -1.46 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.966 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 59.9 mm-40 -123.56 148.74 46.05 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.834 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.5 m95 -109.34 125.97 52.9 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -133.62 140.57 46.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -74.84 134.69 41.67 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.21 8.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.449 -0.9 . . . . 0.0 113.115 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.2 p -42.99 -45.65 5.16 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 111.636 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -61.61 -20.95 63.92 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.156 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -76.68 -20.8 56.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 122.841 0.456 . . . . 0.0 111.184 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.625 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 tt . . . . . 0 N--CA 1.439 -0.98 0 CA-C-O 121.045 0.45 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 21.5 Cg_exo -60.72 171.28 3.69 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.124 1.882 . . . . 0.0 112.771 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -72.57 126.31 29.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.297 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.57 111.33 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.8 57.71 5.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.779 2.319 . . . . 0.0 110.815 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 33.4 ptt180 -88.17 62.63 6.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.389 1.09 . . . . 0.0 113.815 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.67 -61.77 1.53 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.193 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.27 23.0 5.85 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.606 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 21.6 mt-30 -142.26 102.22 4.06 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 113.827 -1.186 . . . . 0.0 109.093 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -69.75 121.59 17.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.958 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.8 m-85 -109.07 124.94 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.411 0.624 . . . . 0.0 112.195 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 15' ' ' ARG . 13.2 p -95.18 172.45 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.372 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 14' ' ' VAL . 31.9 tpt180 -90.62 118.85 30.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 9.0 tptp -118.7 -175.92 2.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.43 96.19 0.24 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.915 1.34 . . . . 0.0 111.556 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.54 9.66 9.78 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 111.716 -2.493 . . . . 0.0 113.611 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 44.9 mm-40 -124.14 153.51 41.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.958 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.3 m95 -97.89 141.22 31.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -143.28 141.77 26.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.69 -176.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.94 132.27 43.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 ' HB ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -119.39 -27.57 5.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 p -40.1 -51.58 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.792 0.806 . . . . 0.0 112.257 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -54.92 -35.69 64.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.721 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.9 m-30 -60.55 -27.93 68.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.136 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.611 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.824 ' HB ' ' NE1' ' A' ' 20' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 3' ' ' ILE . 73.0 Cg_endo -85.36 -40.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.845 2.363 . . . . 0.0 117.842 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 12.1 tpp180 -81.85 43.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . . . -104.63 91.41 4.11 Favored Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HB2' ' OD1' ' A' ' 9' ' ' ASP . 85.4 Cg_endo -86.34 140.89 6.63 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.936 1.758 . . . . 0.0 111.101 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -115.49 25.83 10.51 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.289 1.042 . . . . 0.0 111.716 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 7' ' ' PRO . 13.8 p-10 -92.52 59.55 3.38 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.664 -1.607 . . . . 0.0 113.311 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.75 16.32 80.86 Favored Glycine 0 CA--C 1.51 -0.221 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.336 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.602 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -74.63 104.02 5.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.249 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.914 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 4.9 m-85 -95.97 118.74 33.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.343 0.592 . . . . 0.0 112.113 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.4 p -84.02 162.7 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.745 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 14' ' ' VAL . 73.6 mtp85 -85.97 131.83 34.2 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -128.54 173.69 10.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 99.54 1.7 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.512 1.148 . . . . 0.0 109.773 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.25 10.79 53.91 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-N 112.476 -2.147 . . . . 0.0 113.734 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -124.95 147.53 48.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 43.0 m95 -108.16 137.44 46.13 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -142.39 138.84 29.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.138 -175.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD11 ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -73.4 134.0 43.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.4 OUTLIER -114.46 -31.83 6.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.496 -177.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.5 p -46.69 -43.33 17.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.753 0.787 . . . . 0.0 111.224 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 t -52.25 -35.71 50.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.609 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 20.4 m-85 -62.63 -14.58 44.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.324 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.302 -179.345 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' HA2' ' A' ' 18' ' ' GLY . 37.6 mm . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.89 175.43 4.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.0 112.986 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.15 120.6 16.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -70.67 115.99 41.14 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.946 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.03 53.9 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.734 2.29 . . . . 0.0 110.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -89.59 67.46 7.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.653 1.216 . . . . 0.0 112.516 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.23 69.37 3.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.583 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 21.96 57.3 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.844 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 1.048 ' HB3' HD21 ' A' ' 22' ' ' LEU . 65.7 mt-30 -143.55 114.54 7.78 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -73.38 132.77 43.4 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.238 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.767 ' HD1' ' N ' ' A' ' 21' ' ' VAL . 26.2 m-85 -117.48 123.7 46.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.883 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.539 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -84.48 156.56 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 68.8 mtm180 -90.15 121.6 32.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.83 -174.17 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.57 99.27 0.96 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.414 1.102 . . . . 0.0 110.794 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 57.19 16.74 21.03 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.299 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -122.7 144.44 49.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.51 ' HB3' ' CD1' ' A' ' 13' ' ' TYR . 34.2 m95 -106.91 136.58 46.51 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.767 ' N ' ' HD1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -140.29 135.7 36.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.637 -176.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.048 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -66.03 127.89 33.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -120.84 -31.47 4.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.117 -1.033 . . . . 0.0 112.375 -176.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 5.2 p -47.34 -42.85 22.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.095 0.95 . . . . 0.0 110.318 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 26' ' ' PHE . 5.5 t -54.79 -43.6 73.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.072 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.469 ' CD1' HG23 ' A' ' 25' ' ' THR . 14.9 m-30 -59.68 -42.67 93.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.998 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.597 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.575 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 28.6 mm . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.06 -175.68 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.452 2.102 . . . . 0.0 112.642 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -83.86 132.8 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.2 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -98.58 121.98 54.79 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.889 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.9 Cg_endo -87.34 49.03 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.096 2.53 . . . . 0.0 109.281 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 34.9 ptt180 -86.47 68.95 10.35 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.481 1.134 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.46 -78.53 0.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.277 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.58 19.72 44.07 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.661 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 90.2 mt-30 -135.22 106.72 6.86 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.736 ' HB3' HD23 ' A' ' 23' ' ' LEU . . . -69.52 102.56 1.84 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 11' ' ' GLN . 5.3 m-85 -104.25 133.09 49.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.44 0.638 . . . . 0.0 111.968 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.3 152.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.574 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -85.86 115.95 23.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.684 0.754 . . . . 0.0 111.236 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE2' HG21 ' A' ' 21' ' ' VAL . 24.5 ttmm -103.38 86.2 2.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.975 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.26 -3.03 2.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.771 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 138.68 -9.32 3.41 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.234 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -98.3 139.57 33.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 117.376 0.588 . . . . 0.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 81.4 m95 -88.34 122.21 31.61 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.226 1.013 . . . . 0.0 108.582 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 m -133.08 148.72 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.457 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 23' ' ' LEU . 9.7 tp -78.77 147.92 33.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -84.49 -31.81 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.215 -177.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.493 ' OG ' ' HG ' ' A' ' 22' ' ' LEU . 23.9 p -48.49 -41.93 31.33 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.721 0.772 . . . . 0.0 111.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -52.97 -35.99 59.68 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.709 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -58.39 -59.82 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.311 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.725 -179.018 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.252 0.072 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.62 -176.33 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.33 2.02 . . . . 0.0 111.825 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -79.83 137.8 37.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -100.11 108.15 50.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -80.33 62.84 8.66 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.948 2.432 . . . . 0.0 109.958 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 15.1 ptm180 -78.68 14.42 1.32 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.125 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -88.73 64.97 7.54 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.848 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.69 7.47 10.66 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 53.3 mt-30 -150.24 111.98 4.52 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.21 101.66 2.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.6 m-30 -98.82 128.05 44.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.664 0.745 . . . . 0.0 112.665 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -96.6 155.33 3.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.926 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.596 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 64.5 mtm180 -77.16 123.22 26.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.148 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 21' ' ' VAL . 3.0 tppt? -117.86 32.89 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.418 1.104 . . . . 0.0 109.004 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.48 -26.77 0.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.277 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . -152.11 -7.95 0.11 Allowed Glycine 0 C--N 1.291 -1.949 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.008 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 35.8 mt-10 -123.11 144.03 49.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.353 0.577 . . . . 0.0 111.43 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.877 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 28.3 m95 -105.2 121.29 43.54 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -130.21 143.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.469 -174.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.647 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -76.98 138.85 39.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 -27.44 15.34 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.147 -177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' HD22 ' A' ' 22' ' ' LEU . 21.5 p -42.04 -48.14 4.59 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.98 0.895 . . . . 0.0 111.797 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.2 p -51.64 -33.75 34.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.511 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -58.75 -60.33 4.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.895 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.535 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 30.3 mm . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.641 0.257 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.55 175.13 7.43 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.69 2.26 . . . . 0.0 112.426 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -73.39 132.33 42.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -92.11 109.06 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.93 60.73 7.63 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.784 2.322 . . . . 0.0 110.492 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -82.85 65.6 8.05 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 123.024 1.392 . . . . 0.0 111.097 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.86 77.82 1.64 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.664 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.7 1.45 61.9 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.685 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 15.8 mt-30 -136.59 99.79 4.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.49 104.57 2.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.134 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.887 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.8 m-30 -95.66 130.23 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.233 0.539 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.3 p -97.81 160.77 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.095 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' N ' HG22 ' A' ' 14' ' ' VAL . 2.3 ptp180 -80.2 128.43 33.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.893 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.955 ' HE2' HG21 ' A' ' 21' ' ' VAL . 19.4 ttmm -123.4 43.39 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.21 3.91 2.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.473 -1.239 . . . . 0.0 113.683 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 162.17 -21.2 0.19 Allowed Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 38.4 mt-10 -102.03 144.56 30.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.36 . . . . 0.0 111.937 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.887 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.2 m95 -98.81 128.81 45.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.261 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.955 HG21 ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.23 137.94 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -73.1 130.38 40.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.71 -26.35 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 p -40.22 -48.91 2.65 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.882 0.849 . . . . 0.0 112.289 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -58.64 -37.61 76.31 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.337 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.0 m-30 -59.39 -57.25 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.49 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.321 -0.847 . . . . 0.0 109.973 -178.52 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.747 HD11 ' HA2' ' A' ' 18' ' ' GLY . 20.2 mt . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 111.483 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -166.56 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.948 2.432 . . . . 0.0 112.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -76.56 132.6 39.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 127.68 89.57 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.629 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.88 67.13 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.149 2.566 . . . . 0.0 111.63 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -87.54 57.16 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.947 1.355 . . . . 0.0 112.039 -178.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -100.42 47.92 0.92 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.685 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.34 2.53 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.625 ' HB3' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -135.18 112.5 10.52 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 22' ' ' LEU . . . -83.08 108.33 16.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.198 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.852 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.5 m-30 -95.11 136.26 35.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.958 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.67 157.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.587 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 69.3 mtm180 -84.39 123.96 30.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -118.68 177.97 4.64 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 100.99 0.72 Allowed 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.074 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.747 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . 61.9 12.36 35.33 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.177 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -123.91 148.06 47.17 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.852 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 27.7 m95 -109.88 130.88 55.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -141.22 152.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.628 -176.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 11' ' ' GLN . 13.7 tp -76.27 140.94 41.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -27.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.663 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p -47.56 -45.46 27.0 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-O 121.941 0.877 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -55.34 -32.73 62.77 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.962 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -58.57 -34.6 71.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.753 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.69 155.0 71.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.082 1.855 . . . . 0.0 112.125 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 20.6 ttp-105 -70.68 119.08 14.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -63.16 136.46 96.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.227 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 55.78 5.81 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.899 2.4 . . . . 0.0 110.22 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 31.9 ptt180 -87.83 65.09 8.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.405 1.097 . . . . 0.0 112.801 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -99.73 -50.5 4.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.908 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 10.82 15.85 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 7.6 pt20 -152.12 105.97 3.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.04 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.631 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -64.13 125.3 24.05 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.179 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.108 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 3.3 m-85 -112.93 127.84 56.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.42 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 21' ' ' VAL . 3.9 p -91.07 162.19 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.691 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.593 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 46.6 mtm180 -92.65 122.64 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 25.9 mmtp -106.36 167.94 9.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -44.81 -29.58 0.81 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 21.29 0.13 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.115 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 58.2 mm-40 -126.39 146.69 49.96 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 1.108 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.1 m95 -104.6 128.14 52.54 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -134.58 147.42 29.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.044 -174.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.84 138.78 44.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.54 -28.94 3.53 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 p -45.55 -44.11 12.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.141 0.972 . . . . 0.0 111.397 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.9 p -59.56 -29.5 67.97 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.769 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -67.33 -14.51 62.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.702 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.683 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -86.46 140.95 29.48 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.58 0.228 . . . . 0.0 110.768 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.626 HD13 ' HA2' ' A' ' 18' ' ' GLY . 28.0 mm -86.9 113.49 53.61 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.47 173.39 9.84 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.546 2.164 . . . . 0.0 112.672 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.89 134.04 56.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.71 102.73 20.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 74.6 Cg_endo -79.27 61.44 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.603 2.202 . . . . 0.0 110.717 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 14.6 ptm180 -78.36 13.07 1.66 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.915 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -89.36 63.68 6.53 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 113.791 -1.549 . . . . 0.0 110.252 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.15 -4.39 8.97 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.638 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.772 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 89.3 mt-30 -137.95 103.52 5.0 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.15 94.96 0.54 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.925 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 10.2 m-30 -89.15 118.56 28.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.312 0.577 . . . . 0.0 112.424 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.02 153.39 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.571 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.588 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 8.4 mtp-105 -82.94 121.71 27.34 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 15' ' ' ARG . 1.2 mptm? -131.09 174.11 10.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.54 100.49 0.38 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 122.595 1.188 . . . . 0.0 111.727 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.626 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 58.13 18.22 33.72 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 112.182 -2.281 . . . . 0.0 112.677 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -121.75 142.37 50.26 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.925 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 12.3 m95 -112.81 126.5 55.51 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -137.85 135.29 45.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.918 -174.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.93 130.36 40.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -108.09 -29.68 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 45.5 p -43.83 -44.62 6.97 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.858 0.837 . . . . 0.0 111.59 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.7 t -51.23 -34.38 31.99 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.224 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 24.1 m-85 -66.16 -49.56 66.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.511 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.209 -179.146 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -99.19 136.85 38.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.9 mm -97.53 109.35 50.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.46 172.65 6.32 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.421 2.081 . . . . 0.0 112.938 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 76.0 ttt180 -72.01 131.03 42.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.44 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -95.06 103.42 11.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 5' ' ' ARG . 96.2 Cg_endo -85.66 55.54 3.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.844 2.362 . . . . 0.0 111.193 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -84.13 69.01 10.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.773 1.273 . . . . 0.0 111.7 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.64 75.14 0.93 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.47 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 2.0 27.43 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.722 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 12.8 pt20 -146.66 103.91 3.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.4 105.45 1.16 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.327 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.0 m-30 -94.97 121.14 36.28 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.561 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.35 158.91 2.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.908 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -78.34 128.7 34.06 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.688 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 7.7 tptp -134.04 179.44 6.25 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.89 97.12 1.08 Allowed 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 123.014 1.388 . . . . 0.0 111.35 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.5 16.51 29.25 Favored Glycine 0 C--N 1.3 -1.46 0 CA-C-N 111.641 -2.527 . . . . 0.0 112.966 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 59.9 mm-40 -123.56 148.74 46.05 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.834 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.5 m95 -109.34 125.97 52.9 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -133.62 140.57 46.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -74.84 134.69 41.67 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.77 -26.21 8.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.449 -0.9 . . . . 0.0 113.115 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.2 p -42.99 -45.65 5.16 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.068 0.937 . . . . 0.0 111.636 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -61.61 -20.95 63.92 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.322 -1.763 . . . . 0.0 114.156 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -76.68 -20.8 56.22 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 122.841 0.456 . . . . 0.0 111.184 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.625 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -91.15 169.19 11.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.927 0.394 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 tt -80.15 125.02 82.43 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.98 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 3' ' ' ILE . 21.5 Cg_exo -60.72 171.28 3.69 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.124 1.882 . . . . 0.0 112.771 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -72.57 126.31 29.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.297 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.57 111.33 36.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.958 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.8 57.71 5.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.779 2.319 . . . . 0.0 110.815 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 33.4 ptt180 -88.17 62.63 6.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.389 1.09 . . . . 0.0 113.815 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.67 -61.77 1.53 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.193 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.27 23.0 5.85 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.606 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 21.6 mt-30 -142.26 102.22 4.06 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 113.827 -1.186 . . . . 0.0 109.093 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.6 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -69.75 121.59 17.51 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.958 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.8 m-85 -109.07 124.94 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.411 0.624 . . . . 0.0 112.195 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 15' ' ' ARG . 13.2 p -95.18 172.45 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.372 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 14' ' ' VAL . 31.9 tpt180 -90.62 118.85 30.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 9.0 tptp -118.7 -175.92 2.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.43 96.19 0.24 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.915 1.34 . . . . 0.0 111.556 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.54 9.66 9.78 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 111.716 -2.493 . . . . 0.0 113.611 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 17' ' ' ASP . 44.9 mm-40 -124.14 153.51 41.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.958 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.3 m95 -97.89 141.22 31.14 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 175.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -143.28 141.77 26.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.69 -176.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -72.94 132.27 43.25 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 ' HB ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -119.39 -27.57 5.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.4 p -40.1 -51.58 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.792 0.806 . . . . 0.0 112.257 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -54.92 -35.69 64.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.098 -1.41 . . . . 0.0 112.721 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.9 m-30 -60.55 -27.93 68.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.136 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 C--O 1.245 0.831 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.611 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -82.96 112.47 19.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.824 ' HB ' ' NE1' ' A' ' 20' ' ' TRP . 1.0 OUTLIER -101.19 140.12 21.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 3' ' ' ILE . 73.0 Cg_endo -85.36 -40.41 0.08 OUTLIER 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.845 2.363 . . . . 0.0 117.842 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 12.1 tpp180 -81.85 43.79 0.79 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . . . -104.63 91.41 4.11 Favored Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HB2' ' OD1' ' A' ' 9' ' ' ASP . 85.4 Cg_endo -86.34 140.89 6.63 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.936 1.758 . . . . 0.0 111.101 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -115.49 25.83 10.51 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 122.289 1.042 . . . . 0.0 111.716 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 7' ' ' PRO . 13.8 p-10 -92.52 59.55 3.38 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.664 -1.607 . . . . 0.0 113.311 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.75 16.32 80.86 Favored Glycine 0 CA--C 1.51 -0.221 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.336 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.602 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -74.63 104.02 5.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.249 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.914 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 4.9 m-85 -95.97 118.74 33.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.343 0.592 . . . . 0.0 112.113 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.4 p -84.02 162.7 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.745 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 14' ' ' VAL . 73.6 mtp85 -85.97 131.83 34.2 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -128.54 173.69 10.03 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 99.54 1.7 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.512 1.148 . . . . 0.0 109.773 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.25 10.79 53.91 Favored Glycine 0 C--N 1.305 -1.181 0 CA-C-N 112.476 -2.147 . . . . 0.0 113.734 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -124.95 147.53 48.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 43.0 m95 -108.16 137.44 46.13 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -142.39 138.84 29.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.138 -175.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD11 ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -73.4 134.0 43.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.4 OUTLIER -114.46 -31.83 6.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.496 -177.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.5 p -46.69 -43.33 17.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.753 0.787 . . . . 0.0 111.224 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 t -52.25 -35.71 50.63 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.609 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 20.4 m-85 -62.63 -14.58 44.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.324 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.302 -179.345 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -137.71 133.39 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.567 0.223 . . . . 0.0 110.462 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' HA2' ' A' ' 18' ' ' GLY . 37.6 mm -105.99 108.32 61.41 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.934 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.89 175.43 4.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.0 112.986 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -71.15 120.6 16.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -70.67 115.99 41.14 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.946 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.03 53.9 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.734 2.29 . . . . 0.0 110.912 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -89.59 67.46 7.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.653 1.216 . . . . 0.0 112.516 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.23 69.37 3.73 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.583 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.48 21.96 57.3 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.844 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 1.048 ' HB3' HD21 ' A' ' 22' ' ' LEU . 65.7 mt-30 -143.55 114.54 7.78 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -73.38 132.77 43.4 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.238 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.767 ' HD1' ' N ' ' A' ' 21' ' ' VAL . 26.2 m-85 -117.48 123.7 46.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.883 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.539 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -84.48 156.56 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 68.8 mtm180 -90.15 121.6 32.34 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.83 -174.17 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.57 99.27 0.96 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.414 1.102 . . . . 0.0 110.794 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 3' ' ' ILE . . . 57.19 16.74 21.03 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.299 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -122.7 144.44 49.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.51 ' HB3' ' CD1' ' A' ' 13' ' ' TYR . 34.2 m95 -106.91 136.58 46.51 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.767 ' N ' ' HD1' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -140.29 135.7 36.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.637 -176.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.048 HD21 ' HB3' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -66.03 127.89 33.89 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -120.84 -31.47 4.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.117 -1.033 . . . . 0.0 112.375 -176.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.444 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 5.2 p -47.34 -42.85 22.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.095 0.95 . . . . 0.0 110.318 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 26' ' ' PHE . 5.5 t -54.79 -43.6 73.0 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.072 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.469 ' CD1' HG23 ' A' ' 25' ' ' THR . 14.9 m-30 -59.68 -42.67 93.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.998 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.597 -178.025 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -93.39 118.7 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.603 0.239 . . . . 0.0 110.681 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.575 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 28.6 mm -93.89 108.57 35.94 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.906 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.06 -175.68 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.452 2.102 . . . . 0.0 112.642 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -83.86 132.8 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.2 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -98.58 121.98 54.79 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.889 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.9 Cg_endo -87.34 49.03 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.096 2.53 . . . . 0.0 109.281 177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . 34.9 ptt180 -86.47 68.95 10.35 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 122.481 1.134 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.46 -78.53 0.33 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.277 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.58 19.72 44.07 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.661 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 90.2 mt-30 -135.22 106.72 6.86 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.736 ' HB3' HD23 ' A' ' 23' ' ' LEU . . . -69.52 102.56 1.84 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 11' ' ' GLN . 5.3 m-85 -104.25 133.09 49.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.44 0.638 . . . . 0.0 111.968 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.3 152.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.574 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -85.86 115.95 23.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.684 0.754 . . . . 0.0 111.236 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE2' HG21 ' A' ' 21' ' ' VAL . 24.5 ttmm -103.38 86.2 2.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.975 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.26 -3.03 2.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.771 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 138.68 -9.32 3.41 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.234 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -98.3 139.57 33.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 117.376 0.588 . . . . 0.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 81.4 m95 -88.34 122.21 31.61 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.226 1.013 . . . . 0.0 108.582 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.7 m -133.08 148.72 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.457 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 23' ' ' LEU . 9.7 tp -78.77 147.92 33.17 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -84.49 -31.81 24.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.215 -177.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.493 ' OG ' ' HG ' ' A' ' 22' ' ' LEU . 23.9 p -48.49 -41.93 31.33 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.721 0.772 . . . . 0.0 111.019 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.4 p -52.97 -35.99 59.68 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.733 -1.576 . . . . 0.0 112.709 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -58.39 -59.82 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.311 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.725 -179.018 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -129.49 127.1 40.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -106.63 106.67 58.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.022 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.62 -176.33 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.33 2.02 . . . . 0.0 111.825 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -79.83 137.8 37.05 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -100.11 108.15 50.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -80.33 62.84 8.66 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.948 2.432 . . . . 0.0 109.958 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 15.1 ptm180 -78.68 14.42 1.32 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.125 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -88.73 64.97 7.54 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.848 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.69 7.47 10.66 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 114.667 -1.152 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.647 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 53.3 mt-30 -150.24 111.98 4.52 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.21 101.66 2.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.6 m-30 -98.82 128.05 44.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.664 0.745 . . . . 0.0 112.665 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 21' ' ' VAL . 2.5 p -96.6 155.33 3.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.926 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.596 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 64.5 mtm180 -77.16 123.22 26.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.148 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.684 ' HE2' HG21 ' A' ' 21' ' ' VAL . 3.0 tppt? -117.86 32.89 5.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.418 1.104 . . . . 0.0 109.004 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.48 -26.77 0.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.277 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . -152.11 -7.95 0.11 Allowed Glycine 0 C--N 1.291 -1.949 0 CA-C-N 115.183 -0.917 . . . . 0.0 113.008 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 35.8 mt-10 -123.11 144.03 49.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.353 0.577 . . . . 0.0 111.43 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.877 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 28.3 m95 -105.2 121.29 43.54 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -130.21 143.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.469 -174.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.647 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -76.98 138.85 39.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 -27.44 15.34 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.147 -177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' HD22 ' A' ' 22' ' ' LEU . 21.5 p -42.04 -48.14 4.59 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.98 0.895 . . . . 0.0 111.797 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.2 p -51.64 -33.75 34.78 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.511 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -58.75 -60.33 4.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.895 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.243 0.754 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.322 -0.311 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -130.49 177.05 7.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.709 0.29 . . . . 0.0 110.763 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.535 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 30.3 mm -91.51 108.97 33.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.433 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.55 175.13 7.43 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.69 2.26 . . . . 0.0 112.426 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -73.39 132.33 42.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.225 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 20' ' ' TRP . . . -92.11 109.06 35.02 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -81.93 60.73 7.63 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.784 2.322 . . . . 0.0 110.492 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -82.85 65.6 8.05 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 123.024 1.392 . . . . 0.0 111.097 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.86 77.82 1.64 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.664 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.7 1.45 61.9 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.685 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 15.8 mt-30 -136.59 99.79 4.17 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.49 104.57 2.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.134 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.887 ' CD2' ' HB3' ' A' ' 20' ' ' TRP . 8.8 m-30 -95.66 130.23 42.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.233 0.539 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 15' ' ' ARG . 7.3 p -97.81 160.77 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.095 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' N ' HG22 ' A' ' 14' ' ' VAL . 2.3 ptp180 -80.2 128.43 33.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.893 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.955 ' HE2' HG21 ' A' ' 21' ' ' VAL . 19.4 ttmm -123.4 43.39 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.21 3.91 2.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.473 -1.239 . . . . 0.0 113.683 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 3' ' ' ILE . . . 162.17 -21.2 0.19 Allowed Glycine 0 C--N 1.284 -2.312 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 38.4 mt-10 -102.03 144.56 30.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.36 . . . . 0.0 111.937 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.887 ' HB3' ' CD2' ' A' ' 13' ' ' TYR . 24.2 m95 -98.81 128.81 45.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.261 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.955 HG21 ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.23 137.94 45.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HG ' ' HB3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -73.1 130.38 40.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.71 -26.35 7.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 p -40.22 -48.91 2.65 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.882 0.849 . . . . 0.0 112.289 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 26' ' ' PHE . 12.9 t -58.64 -37.61 76.31 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.337 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CD1' HG23 ' A' ' 25' ' ' THR . 15.0 m-30 -59.39 -57.25 13.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.49 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.321 -0.847 . . . . 0.0 109.973 -178.52 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.706 -0.557 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -73.96 117.98 16.38 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.747 HD11 ' HA2' ' A' ' 18' ' ' GLY . 20.2 mt -94.61 115.82 65.72 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.929 0.395 . . . . 0.0 111.483 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -166.56 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.948 2.432 . . . . 0.0 112.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -76.56 132.6 39.6 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 127.68 89.57 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.629 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.88 67.13 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.149 2.566 . . . . 0.0 111.63 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 0.6 OUTLIER -87.54 57.16 4.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 122.947 1.355 . . . . 0.0 112.039 -178.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -100.42 47.92 0.92 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 112.787 -2.006 . . . . 0.0 110.685 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.34 2.53 27.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.625 ' HB3' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -135.18 112.5 10.52 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.53 ' O ' HD12 ' A' ' 22' ' ' LEU . . . -83.08 108.33 16.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.198 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.852 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 6.5 m-30 -95.11 136.26 35.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.958 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 p -98.67 157.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.587 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 69.3 mtm180 -84.39 123.96 30.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -118.68 177.97 4.64 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 100.99 0.72 Allowed 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.074 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.747 ' HA2' HD11 ' A' ' 3' ' ' ILE . . . 61.9 12.36 35.33 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.177 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -123.91 148.06 47.17 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.852 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 27.7 m95 -109.88 130.88 55.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -141.22 152.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.628 -176.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 11' ' ' GLN . 13.7 tp -76.27 140.94 41.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -27.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.663 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 p -47.56 -45.46 27.0 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-O 121.941 0.877 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -55.34 -32.73 62.77 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.962 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -58.57 -34.6 71.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 C--O 1.242 0.701 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.753 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -85.22 120.51 26.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.838 0.351 . . . . 0.0 110.192 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 mt -91.46 126.7 53.52 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.69 155.0 71.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.082 1.855 . . . . 0.0 112.125 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 20.6 ttp-105 -70.68 119.08 14.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 20' ' ' TRP . . . -63.16 136.46 96.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.227 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 55.78 5.81 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.899 2.4 . . . . 0.0 110.22 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' GLN . 31.9 ptt180 -87.83 65.09 8.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.405 1.097 . . . . 0.0 112.801 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -99.73 -50.5 4.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.908 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 10.82 15.85 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 7.6 pt20 -152.12 105.97 3.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.04 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.631 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -64.13 125.3 24.05 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.179 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.108 ' HD2' ' HB3' ' A' ' 20' ' ' TRP . 3.3 m-85 -112.93 127.84 56.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.42 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 21' ' ' VAL . 3.9 p -91.07 162.19 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.691 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.593 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 46.6 mtm180 -92.65 122.64 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 25.9 mmtp -106.36 167.94 9.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -44.81 -29.58 0.81 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 21.29 0.13 Allowed Glycine 0 C--N 1.302 -1.323 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.115 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 16' ' ' LYS . 58.2 mm-40 -126.39 146.69 49.96 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 1.108 ' HB3' ' HD2' ' A' ' 13' ' ' TYR . 35.1 m95 -104.6 128.14 52.54 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -134.58 147.42 29.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.044 -174.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.84 138.78 44.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -124.54 -28.94 3.53 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 p -45.55 -44.11 12.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.141 0.972 . . . . 0.0 111.397 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.9 p -59.56 -29.5 67.97 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.447 -1.706 . . . . 0.0 112.769 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -67.33 -14.51 62.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.702 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.683 -178.914 . . . . . . . . 0 0 . 1 stop_ save_